We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
-12.71%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$326M
AUM Growth
+$190M
Cap. Flow
+$241M
Cap. Flow %
73.95%
Top 10 Hldgs %
96.62%
Holding
33
New
4
Increased
7
Reduced
9
Closed
10

Sector Composition

Rank Sector Weight
1 Healthcare 19.94%
2 Energy 0.03%
3 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KYNB
26
CALL
Kyntra Bio
KYNB
$29.4M
-11,080
Closed -$748K
OPK icon
27
CALL
Opko Health
OPK
$1.02B
-236,800
Closed -$514K
PLTR icon
28
Palantir
PLTR
$413B
-36,700
Closed -$563K
SGRY icon
29
CALL
Surgery Partners
SGRY
$2.03B
-175,000
Closed -$7.87M
SGRY icon
30
Surgery Partners
SGRY
$2.03B
-15,000
Closed -$675K
TQQQ icon
31
ProShares UltraPro QQQ
TQQQ
$37.9B
-140,000
Closed -$414K
MRTX
32
CALL
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
-50,000
Closed -$1.81M
MRTX
33
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
-152,600
Closed -$5.51M

Similar funds

Oracle Investment Management's Q3 2023 Portfolio in Review

As of Q3 2023, Oracle Investment Management held 33 positions worth $326M, up 140% from $136M the previous quarter. Its ten largest holdings account for 97% of the portfolio.

Oracle Investment Management deployed $241M of net new capital in Q3 2023, opening 4 new positions and adding to 7 existing holdings. Its largest new stake was NanoString Technologies, Inc.: 485,886 shares worth $836K.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 77% a quarter earlier, followed by Energy and Technology.

On the sell side, the largest reduction was Opko Health, an estimated $6.91M trimmed.

  • Oracle Investment Management's largest Q3 2023 buy was NanoString Technologies, Inc.: 485,886 shares worth $836K.
  • Oracle Investment Management added most to GeneDx Holdings in Q3 2023, an estimated $705K increase.
  • Oracle Investment Management's biggest Q3 2023 reduction was Opko Health, cutting an estimated $6.91M.
  • Oracle Investment Management fully exited Mirati Therapeutics, Inc. Common Stock in Q3 2023, selling an estimated $5.51M.
  • Oracle Investment Management's ten largest holdings make up 97% of its $326M portfolio in Q3 2023.
  • Oracle Investment Management opened 4 new positions and closed 10 in Q3 2023.
  • Oracle Investment Management's portfolio value rose 140% quarter-over-quarter to $326M.

Based on Oracle Investment Management's 13F filing for Q3 2023, filed 14 Nov 2023.